Gianluca Franceschini
Gianluca Franceschini, PhD is an expert in Surgery at Agostino Gemelli University Polyclinic (Italy). As of October 2026, ScienceLeadR ranks Gianluca Franceschini in the top 1% of experts worldwide for Breast Diseases and Breast Neoplasms. Gianluca Franceschini has authored 425 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 8 of them ongoing. SLR score: 1,538 (community average: 125). How the SLR is computed.
LeadR Profile
Surgery
Subspecialties: Oncology - Plastic And Esthetic Surgery
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Full Professor of General Surgery and Head of Breast Unit at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Catholic University, Rome - Italy.
Senior breast surgeon with expertise in the surgical treatment of breast tumors and oncoplastic techniques; over 4.000 surgical procedures for breast cancer in the past 10 years.
Author of over 200 scientific papers in international journals and 15 textbook chapters (Orcid ID 0000-0002-2950-3395; Scopus Author ID 23027478400).
Professor at the School of Specialization in General Surgery, Plastic Surgery and Oncology at the Catholic University of Rome, Italy.
Director of the First-Level University Master’s program in "Breast Nurse" and "Integrated Therapies in Female Oncological Diseases" at the Catholic University of the Sacred Heart since 2024.
Full Member of the Teaching College for the PhD programs at the Catholic University of the Sacred Heart, accredited by the Ministry, since 2010.
Scientific Director of several research projects on the surgical treatment of breast cancers, funded through competitive grants with peer review.
Principal Investigator of several scientific trials commissioned by the Fondazione Policlinico Universitario Agostino Gemelli IRCCS of Rome and the Scientific Director (Local Investigator) of several international multicenter trialson the surgical treatment of breast neoplasms.
Member of Editorial Board for several scientific journals.
Winner of the price with Medal, awarded by the President of "The Royal College of Radiologists", for the best work published in the scientific journal "Clinical Radiology" in 2010 (Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness. Clinical Radiology. 65; 2010; 1005-1012).
Winner of the prize about "The Awards for High Quality Publications" awarded by the Catholic University in 2020 (Internal surgical use of biodegradable carbohydrate polymers. Warning for a conscious and proper use of oxidized regenerated cellulose. Carbohydr Polym. 2019 Jul 15;216: 213-216).
Creator of the "ADAPTED01 Breast Cancer" application, available on the Google Play Store, used in breast cancer oncology.
Founding Partner and Member of the non-profit Organization, “Susan G. Komen Italia”.
Research and Teaching Fellow in the HopeXChange Medical Centre in Kumasi (Ghana).
Member of “REPRISE” (Register of the Scientific Experts for Italian Ministry of Education -- MIUR).
Permanent Member of the College of Italian Breast Surgeons.
He was included in the "World's Top 2% Scientists" ranking, published by Stanford University and Elsevier, which includes the world's most influential scientists, in relation to scientific production in 2021, 2022, 2023, 2024, 2025.
Organizations
Career arc: 1987 - 2026
Number : 425
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 12
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 7
Ongoing Clinical Trials
8 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement NCT07278726 — lymph nodes, breast neoplasms, neoplasms, sentinel lymph node, biopsy, lymph, breast, therapeutics, sentinel lymph node biopsy, dissection, surgeons | N/A | Recruiting | 2026 |
| IntraOperative UltraSound Guided vs Wire Guided vs Magnetic Seed Guided Breast Conserving Surgery for Non palpable Tumors NCT07185568 — hydrogel, polyethylene glycol dimethacrylate, hydrogels, muscles, lymph nodes, breast neoplasms, neoplasms, multiple chronic conditions, biopsy, seeds, steel, lymph, subcutaneous tissue, breast, muscle, skeletal, tissues, wounds and injuries, needles, adipose tissue | N/A | Not yet recruiting | 2026 |
| Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery NCT07140172 — radiotherapy, quality of life, lymphoid tissue, lymph nodes, breast neoplasms, neoplasms, sentinel lymph node, biopsy, lymph, breast, tissues, sentinel lymph node biopsy, dissection, lymphedema | N/A | Recruiting | 2026 |
| The OPBC 07 microNAC Study NCT06529302 — lymph nodes, breast neoplasms, neoplasms, drug therapy, neoplasm micrometastasis, lymph, breast, dissection, chemotherapy | N/A | Active not recruiting | 2024 |
| Evaluation of Recurrence Risk Factors in Locally Advanced Breast Cancer Patients Underwent Neoadjuvant Chemotherapy NCT06441240 — triple negative breast neoplasms, breast neoplasms, neoplasms, drug therapy, chemotherapy, adjuvant, breast, risk factors, therapeutics, neoplasm recurrence, local, chemotherapy | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map